OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KCa1.1 K+ Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model
Susumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13553-13553
Open Access | Times Cited: 13
Susumu Ohya, Junko Kajikuri, Kyoko Endo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13553-13553
Open Access | Times Cited: 13
Showing 13 citing articles:
Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 80, pp. 104112-104112
Closed Access | Times Cited: 28
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 80, pp. 104112-104112
Closed Access | Times Cited: 28
Potassium channels, tumorigenesis and targeted drugs
Cong Xia, Can Liu, Shuangyi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114673-114673
Open Access | Times Cited: 14
Cong Xia, Can Liu, Shuangyi Ren, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114673-114673
Open Access | Times Cited: 14
Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells
Mahima Verma, Shireen Fatima, Mοhd Saeed, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Mahima Verma, Shireen Fatima, Mοhd Saeed, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
The modulation of ion channels in cancer chemo-resistance
Jiayu Zhao, Mei Li, Jiao Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Jiayu Zhao, Mei Li, Jiao Xu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?
Maryne Dupuy, Maxime Guéguinou, Marie Potier‐Cartereau, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115774-115774
Open Access | Times Cited: 8
Maryne Dupuy, Maxime Guéguinou, Marie Potier‐Cartereau, et al.
Biochemical Pharmacology (2023) Vol. 216, pp. 115774-115774
Open Access | Times Cited: 8
Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatment
Linxi Zhang, Changyu Ren, Jiao Liu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103995-103995
Closed Access | Times Cited: 2
Linxi Zhang, Changyu Ren, Jiao Liu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103995-103995
Closed Access | Times Cited: 2
Let’s Go 3D! New Generation of Models for Evaluating Drug Response and Resistance in Prostate Cancer
Tina Petrić, Maja Sabol
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5293-5293
Open Access | Times Cited: 5
Tina Petrić, Maja Sabol
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5293-5293
Open Access | Times Cited: 5
Down-Regulation of CYP3A4 by the KCa1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models
Susumu Ohya, Junko Kajikuri, Hiroaki Kito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15672-15672
Open Access | Times Cited: 4
Susumu Ohya, Junko Kajikuri, Hiroaki Kito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15672-15672
Open Access | Times Cited: 4
Advances in ion channel high throughput screening: where are we in 2023?
Mark Dallas, Damian C. Bell
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 3, pp. 331-337
Open Access | Times Cited: 3
Mark Dallas, Damian C. Bell
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 3, pp. 331-337
Open Access | Times Cited: 3
Single ion channel recording in 3D culture of stem cells using patch-clamp technique
V. I. Chubinskiy-Nadezhdin, Anastasia V. Sudarikova, Mariia Shorokhova, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 619, pp. 22-26
Open Access | Times Cited: 4
V. I. Chubinskiy-Nadezhdin, Anastasia V. Sudarikova, Mariia Shorokhova, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 619, pp. 22-26
Open Access | Times Cited: 4
Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model
J.L. Bastian, Philip Zeuschner, Michael Stöckle, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
J.L. Bastian, Philip Zeuschner, Michael Stöckle, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Transcriptional Up-Regulation of FBXW7 by KCa1.1 K+ Channel Inhibition through the Nrf2 Signaling Pathway in Human Prostate Cancer LNCaP Cell Spheroid Model
Susumu Ohya, Hiroaki Kito, Junko Kajikuri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6019-6019
Open Access
Susumu Ohya, Hiroaki Kito, Junko Kajikuri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6019-6019
Open Access
Overcoming chemoresistance by Ca<sup>2＋</sup>-activated K<sup>＋</sup> channel inhibition in cancer spheroid models
Susumu Ohya
Folia Pharmacologica Japonica (2023) Vol. 158, Iss. 6, pp. 478-482
Closed Access
Susumu Ohya
Folia Pharmacologica Japonica (2023) Vol. 158, Iss. 6, pp. 478-482
Closed Access
